Early detection value of miR-29a in patients with acute myocardial infarction - Summary - MDSpire

Early detection value of miR-29a in patients with acute myocardial infarction

  • By

  • Yanqing, Wang

  • Peng, Gao

  • Yawei, Duan

  • Hanqi, Su

  • Haibo, Wu

  • Yuan, Jia

  • Zhang, Yue

  • Jia, Liu

  • Hongxiao, Li

  • 李, 向明

  • Wenjuan, Li

  • Xiaoshuai, Shi

  • Tingting, Liu

  • Teng, Huang

  • Rongpin, Du

  • March 23, 2026

  • 0 min

Share

Objective:

To evaluate the diagnostic and prognostic potential of miR-29a as a marker for myocardial remodeling in AMI patients.

Key Findings:
  • Serum miR-29a levels were significantly elevated in STEMI patients compared to controls.
  • MiR-29a levels correlated positively with sST2, NT-proBNP, and the Tei index.
  • MiR-29a levels inversely correlated with left ventricular ejection fraction (LVEF).
  • The combination of miR-29a with NT-proBNP and/or sST2 improved diagnostic accuracy.
Interpretation:

Serum miR-29a is a promising biomarker for early detection of myocardial remodeling in AMI, enhancing diagnostic and prognostic capabilities.

Limitations:
  • The study involved a relatively small sample size.
  • Focus was limited to patients with STEMI from anterior descending branch occlusion.
Conclusion:

Serum miR-29a shows significant potential as a biomarker for early detection of myocardial remodeling in AMI, providing valuable diagnostic and prognostic insights.

Original Source(s)

Early detection value of miR-29a in patients with acute myocardial infarction

  • by Yanqing, Wang , Peng, Gao , Yawei, Duan , Hanqi, Su , Haibo, Wu , Yuan, Jia , Zhang, Yue , Jia, Liu , Hongxiao, Li , 李, 向明 , Wenjuan, Li , Xiaoshuai, Shi , Tingting, Liu , Teng, Huang , Rongpin, Du

  • March 23, 2026

Related Content

MRI-derived extracellular volume as a biomarker of cancer therapy cardiotoxicity: systematic review and meta-analysis

Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trials

Development and implementation of a HAPA-based exercise rehabilitation program for patients with chronic heart failure